Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
Major depressive disorder (MDD) is a serious mental disease with negative effects on both mental and physical health of the patient. Currently, antidepressants are among the major ways to ease or treat MDD. However, the existing antidepressants have limited efficacy in treating MDD, with a large fra...
Main Authors: | Juncai Xin, Meng Yuan, Yonglin Peng, Ju Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00151/full |
Similar Items
-
Less basal thyrotropin levels predict antidepressant response in patients with major depression
by: R. Navinés, et al.
Published: (2022-06-01) -
A study to identify unrecognized bipolar disorder in patients of major depressive disorder taking antidepressants
by: Kinjal Bhupendrasinh Chauhan, et al.
Published: (2022-12-01) -
Addition of aerobic exercise to antidepressant drug monotherapy for major depressive disorder in adults
by: Camila Sanhueza Pastén, et al.
Published: (2022-01-01) -
The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
by: Paweł Moćko, et al.
Published: (2023-09-01) -
Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)